DK0654263T3 - Fremgangsmåde til fremstilling af et præparat med langvarig frigivelse - Google Patents
Fremgangsmåde til fremstilling af et præparat med langvarig frigivelseInfo
- Publication number
- DK0654263T3 DK0654263T3 DK94308493T DK94308493T DK0654263T3 DK 0654263 T3 DK0654263 T3 DK 0654263T3 DK 94308493 T DK94308493 T DK 94308493T DK 94308493 T DK94308493 T DK 94308493T DK 0654263 T3 DK0654263 T3 DK 0654263T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- sustained release
- carrier
- mixture
- agglomerates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9324045A GB2284760B (en) | 1993-11-23 | 1993-11-23 | A method of preparing pharmaceutical compositions by melt pelletisation |
GB9403922A GB2288117A (en) | 1994-03-01 | 1994-03-01 | Sustained release morphine |
GB9404544A GB9404544D0 (en) | 1994-03-09 | 1994-03-09 | Controlled release formulation |
GB9404928A GB2287880A (en) | 1994-03-14 | 1994-03-14 | Production of sustained release compositions |
EP94303128A EP0624366B1 (en) | 1993-05-10 | 1994-04-29 | Controlled release formulation containing tramadol |
EP94304144A EP0636370B2 (en) | 1993-07-01 | 1994-06-09 | Sustained release compositions containing morphine |
GB9411842A GB9411842D0 (en) | 1994-06-14 | 1994-06-14 | Pharmaceutical preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0654263T3 true DK0654263T3 (da) | 2002-04-29 |
Family
ID=27562143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94308493T DK0654263T3 (da) | 1993-11-23 | 1994-11-17 | Fremgangsmåde til fremstilling af et præparat med langvarig frigivelse |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0654263B1 (da) |
JP (2) | JP3411114B2 (da) |
CN (1) | CN1121213C (da) |
AT (1) | ATE212224T1 (da) |
AU (1) | AU682223C (da) |
BG (1) | BG62429B1 (da) |
CZ (1) | CZ289650B6 (da) |
DE (1) | DE69429710T2 (da) |
DK (1) | DK0654263T3 (da) |
ES (1) | ES2168290T3 (da) |
FI (1) | FI113335B (da) |
HU (1) | HU217205B (da) |
IL (1) | IL111709A (da) |
NO (1) | NO314124B1 (da) |
NZ (1) | NZ264953A (da) |
PT (1) | PT654263E (da) |
SK (1) | SK280496B6 (da) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
GB9519363D0 (en) * | 1995-09-22 | 1995-11-22 | Euro Celtique Sa | Pharmaceutical formulation |
GB9713549D0 (en) * | 1996-10-18 | 1997-09-03 | Euro Celtique Sa | Pharmaceutical combination formulation |
BE1010803A3 (fr) * | 1996-12-16 | 1999-02-02 | Therabel Research Sa | Comprimes pharmaceutiques a liberation prolongee a base de tramadol et leur preparation. |
DE19729487A1 (de) * | 1997-07-10 | 1999-01-14 | Dresden Arzneimittel | Verfahren zur Herstellung von Wirkstoff-Zubereitungen mit kontrollierter Freisetzung aus einer Matrix |
RS49982B (sr) | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
WO1999032119A1 (en) | 1997-12-22 | 1999-07-01 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
DE19901687B4 (de) * | 1999-01-18 | 2006-06-01 | Grünenthal GmbH | Opioide Analgetika mit kontrollierter Wirkstofffreisetzung |
DE19901683B4 (de) * | 1999-01-18 | 2005-07-21 | Grünenthal GmbH | Analgetikum mit kontrollierter Wirkstofffreisetzung |
DE19923551A1 (de) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht |
SK285128B6 (sk) | 1999-12-28 | 2006-07-07 | Zentiva, A. S. | Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy |
ATE493130T1 (de) | 2001-05-11 | 2011-01-15 | Endo Pharmaceuticals Inc | Opioid enthaltende arzneiform gegen missbrauch |
EP2243471A1 (en) | 2002-04-05 | 2010-10-27 | Euro-Celtique S.A. | Matrix for sustained, invariant and independent release of active compounds |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
DE10300325A1 (de) | 2003-01-09 | 2004-07-22 | Hexal Ag | Granulat mit öliger Substanz, Herstellungsverfahren und Tablette |
DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US8075872B2 (en) | 2003-08-06 | 2011-12-13 | Gruenenthal Gmbh | Abuse-proofed dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
DE102004032049A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
PE20060652A1 (es) * | 2004-08-27 | 2006-08-11 | Novartis Ag | Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion |
GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
KR101655455B1 (ko) | 2005-09-09 | 2016-09-07 | 안젤리니 라보팜 엘엘씨 | 일일 1회 투여를 위한 트라조돈 조성물 |
ES2516693T3 (es) | 2006-03-16 | 2014-10-31 | Euro-Celtique S.A. | Esferoides farmacéuticos |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
AU2009207796B2 (en) | 2008-01-25 | 2014-03-27 | Grunenthal Gmbh | Pharmaceutical dosage form |
ES2599031T3 (es) | 2008-05-09 | 2017-01-31 | Grünenthal GmbH | Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización |
DK2405915T3 (da) | 2009-03-10 | 2019-02-11 | Euro Celtique Sa | Farmaceutiske sammensætninger med øjeblikkelig frigivelse omfattende oxycodon og naloxon |
DE102009019268A1 (de) * | 2009-04-28 | 2010-11-11 | Lts Lohmann Therapie-Systeme Ag | Arzneimittel mit poröser Matrix |
NZ596667A (en) | 2009-07-22 | 2013-09-27 | Gruenenthal Chemie | Hot-melt extruded controlled release dosage form |
PT2456424E (pt) | 2009-07-22 | 2013-09-30 | Gruenenthal Gmbh | Forma de dosagem resistente à adulteração e estabilizada contra a oxidação |
MX2013002377A (es) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica. |
CA2808541C (en) | 2010-09-02 | 2019-01-08 | Gruenenthal Gmbh | Tamper resistant dosage form comprising an anionic polymer |
AR087360A1 (es) | 2011-07-29 | 2014-03-19 | Gruenenthal Gmbh | Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato |
MX348054B (es) | 2011-07-29 | 2017-05-25 | Gruenenthal Gmbh | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. |
AU2013225106B2 (en) | 2012-02-28 | 2017-11-02 | Grunenthal Gmbh | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
RS57913B1 (sr) | 2012-04-18 | 2019-01-31 | Gruenenthal Gmbh | Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
JP6445537B2 (ja) | 2013-05-29 | 2018-12-26 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 1個または複数の粒子を含有する改変防止(tamper−resistant)剤形 |
JP6466417B2 (ja) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形 |
JP6449871B2 (ja) | 2013-07-12 | 2019-01-09 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | エチレン−酢酸ビニルポリマーを含有する改変防止剤形 |
KR20180037074A (ko) | 2013-07-23 | 2018-04-10 | 유로-셀티큐 에스.에이. | 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물 |
BR112016010482B1 (pt) | 2013-11-26 | 2022-11-16 | Grünenthal GmbH | Preparação de uma composição farmacêutica em pó por meio de criomoagem |
WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
JP2017516789A (ja) | 2014-05-26 | 2017-06-22 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | エタノール過量放出に対して防護されている多粒子 |
EA035434B1 (ru) | 2015-04-24 | 2020-06-15 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
SE9003296L (sv) * | 1990-10-16 | 1992-04-17 | Kabi Pharmacia Ab | Foerfarande foer att formulera laekemedel |
SE9200858L (sv) * | 1992-03-20 | 1993-09-21 | Kabi Pharmacia Ab | Metod för framställning av pellets med fördröjd frisättning |
CN1230154C (zh) * | 1993-07-01 | 2005-12-07 | 欧洲凯尔特公司 | 缓释组合物及制备药用组合物的方法 |
-
1994
- 1994-11-17 AT AT94308493T patent/ATE212224T1/de active
- 1994-11-17 PT PT94308493T patent/PT654263E/pt unknown
- 1994-11-17 DE DE69429710T patent/DE69429710T2/de not_active Expired - Lifetime
- 1994-11-17 ES ES94308493T patent/ES2168290T3/es not_active Expired - Lifetime
- 1994-11-17 EP EP94308493A patent/EP0654263B1/en not_active Expired - Lifetime
- 1994-11-17 DK DK94308493T patent/DK0654263T3/da active
- 1994-11-18 NZ NZ264953A patent/NZ264953A/en not_active IP Right Cessation
- 1994-11-21 BG BG99198A patent/BG62429B1/bg unknown
- 1994-11-21 CZ CZ19942866A patent/CZ289650B6/cs not_active IP Right Cessation
- 1994-11-21 IL IL11170994A patent/IL111709A/en not_active IP Right Cessation
- 1994-11-22 SK SK1406-94A patent/SK280496B6/sk not_active IP Right Cessation
- 1994-11-22 NO NO19944473A patent/NO314124B1/no not_active IP Right Cessation
- 1994-11-22 HU HU9403353A patent/HU217205B/hu unknown
- 1994-11-22 FI FI945476A patent/FI113335B/fi not_active IP Right Cessation
- 1994-11-23 AU AU79015/94A patent/AU682223C/en not_active Expired
- 1994-11-23 CN CN94118503A patent/CN1121213C/zh not_active Expired - Lifetime
- 1994-11-24 JP JP28993694A patent/JP3411114B2/ja not_active Expired - Lifetime
-
2002
- 2002-09-18 JP JP2002271157A patent/JP2003113075A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO944473L (no) | 1995-05-24 |
BG62429B1 (bg) | 1999-11-30 |
EP0654263B1 (en) | 2002-01-23 |
AU682223C (en) | 2005-03-24 |
CZ286694A3 (en) | 1995-06-14 |
NZ264953A (en) | 1996-11-26 |
NO944473D0 (no) | 1994-11-22 |
CZ289650B6 (cs) | 2002-03-13 |
CN1121213C (zh) | 2003-09-17 |
EP0654263A1 (en) | 1995-05-24 |
IL111709A (en) | 2002-12-01 |
FI945476A (fi) | 1995-05-24 |
DE69429710D1 (de) | 2002-03-14 |
FI113335B (fi) | 2004-04-15 |
ES2168290T3 (es) | 2002-06-16 |
NO314124B1 (no) | 2003-02-03 |
HUT74910A (en) | 1997-03-28 |
HU217205B (hu) | 1999-12-28 |
AU7901594A (en) | 1995-06-01 |
CN1116521A (zh) | 1996-02-14 |
ATE212224T1 (de) | 2002-02-15 |
AU682223B2 (en) | 1997-09-25 |
PT654263E (pt) | 2002-06-28 |
DE69429710T2 (de) | 2002-08-08 |
SK140694A3 (en) | 1995-07-11 |
SK280496B6 (sk) | 2000-03-13 |
JP2003113075A (ja) | 2003-04-18 |
IL111709A0 (en) | 1995-01-24 |
BG99198A (en) | 1995-08-28 |
HU9403353D0 (en) | 1995-02-28 |
JP3411114B2 (ja) | 2003-05-26 |
JPH07196475A (ja) | 1995-08-01 |
FI945476A0 (fi) | 1994-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0654263T3 (da) | Fremgangsmåde til fremstilling af et præparat med langvarig frigivelse | |
NO971965D0 (no) | Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav | |
IL87922A (en) | Pharmaceutical compositions containing dihydropyridine derivatives in combination with metoprolol and process for their preparation | |
HUT61196A (en) | Process for producing pharmaceutical composition which may be dropped in the eye | |
NO179612C (no) | Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser | |
DK0400522T3 (da) | Fremgangsmåde til fremstilling af mikroniserede bionedbrydelige partikler | |
HUT49808A (en) | Process for producing retarde pharmaceutical compositions containing aselastine | |
SE8800080D0 (sv) | Lekemedelskomposition | |
HU9400954D0 (en) | Granulated composition based on peroxidized derivatives which may be used for bleaching hair and process for the preparation of the said composition | |
DE59707630D1 (de) | Verfahren zur Herstellung von Hydroxipivalinsäureneopentylglykolester-Granulaten | |
IL83083A0 (en) | Pyran derivatives,their production and their use as pesticides | |
DK343586A (da) | Farmaceutisk praeparat med kontrolleret og forsinket aktivstoffrigivelse og fremgangsmaade til fremstilling heraf | |
HUT56536A (en) | Process for producing glutaric acid derivatives | |
MX170343B (es) | Procedimiento para la obtencion de copolimeros clorometilados | |
RU92016566A (ru) | Биокерамическая система для ввода биологически активных соединений, способ ее получения, фармацевтическое средство, способ применения биокерамической системы |